Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-20

FDA Approved: PROBENECID — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Probenecid filed by Rising Pharma Holdings, Inc., typically related to changes in labeling or manufacturing for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probenecid (probenecid)

Snippet

SUPPL AP for PROBENECID (PROBENECID)